kund
4 minutes ago
Misleading never provides full information and always omits critical data when results aren’t meaningful. In the case of 3-71, he didn’t provide data for PANSS, the gold standard for Schizophrenia, which was a secondary endpoint. No wonder the market just ignored the PR.